| Bid Price | 3.70p | High Price | 3.70p |
|---|
| Ask Price | 3.80p | Low Price | 3.70p |
|---|
| Open Price | 3.75p | Spread | 2.63% |
|---|
| Prev Close | 3.75p | Volume | 51 |
|---|
Fusion Antibodies PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 24, 2024 | 3.80 | 3.80 | 3.71 | 3.75 | 187,413 |
| Apr 23, 2024 | 3.80 | 3.86 | 3.62 | 3.80 | 533,374 |
| Apr 22, 2024 | 3.75 | 3.90 | 3.76 | 3.80 | 321,656 |
| Apr 19, 2024 | 3.80 | 3.80 | 3.70 | 3.75 | 138,126 |
| Apr 18, 2024 | 3.80 | 3.89 | 3.72 | 3.75 | 355,720 |
Fusion Antibodies PLC Information
| Name | Fusion Antibodies PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDQZGK16 | Epic | FAB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 5,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 95.37 m | Prev Close | 3.75p |
|---|
| PE Ratio | | Market Cap | £3.53 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.03 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -1.004849 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.263538 | Quick Ratio | 1.729242 |
|---|
Fusion Antibodies PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 04/12/23 | BUY | Simon Douglas | CH | 100,565 @ £0.05 | £4,988.00 |
| 04/12/23 | BUY | Adrian Kinkaid | CEO | 101,847 @ £0.05 | £4,991.00 |
| 12/06/23 | BUY | Richard Buick | ED | 68,750 @ £0.07 | £4,950.00 |
| 24/05/23 | PLAC | Colin Walsh | NED | 600,000 @ £0.05 | £30,000.00 |
| 24/05/23 | PLAC | Simon Douglas | CH | 200,000 @ £0.05 | £10,000.00 |
Fusion Antibodies PLC News
